Drug updated on 3/28/2024
Dosage Form | Tablet (oral: 12.5 mg, 100 mg) |
Drug Class | Nitroimidazole antimicrobial |
Ongoing and Completed Studies | ClinicalTrials.gov |
Indication
- Indicated in pediatric patients 2 to 12 years of age for the treatment of Chagas disease (American trypanosomiasis), caused by Trypanosoma cruzi.
Product Monograph / Prescribing Information
Document Title | Year | Source |
---|---|---|
Benznidazole (benznidazole) Prescribing information. | 2017 | Exeltis USA, Inc. Florham Park, NJ |
Systematic Reviews / Meta-Analyses
Clinical Practice Guidelines
Document Title | Year | Source |
---|---|---|
Guidelines for the diagnosis and treatment of Chagas disease. | 2019 | Pan American Health Organization & World Health Organization |